Seres Therapeutics
$3.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.14 (+4.17%) As of 3:31 PM EST today
+$0.14 (+4.17%) Today
Why Robinhood?
You can buy or sell MCRB and other stocks, options, ETFs, and crypto commission-free!
About MCRB
Seres Therapeutics, Inc. operates a microbiome therapeutics platform company, which engages in the development of biological drugs. The firm creates medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. Read More It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. Berry and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Employees
145
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
267.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
193.62K
High Today
$3.53
Low Today
$3.37
Open Price
$3.37
Volume
118.48K
52 Week High
$8.39
52 Week Low
$2.02
Collections
Analyst Ratings
67%
of 6 ratings
Buy
67%
Hold
33%
Sell
0%
MCRB Earnings
-$0.68
-$0.45
-$0.23
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 9, Pre-Market
People Also Bought
TherapeuticsMD
13,705
$1.79
-3.51%CRISPR
26,944
$50.98
+2.18%Intellia Therapeutics
5,384
$12.26
+1.16%Qutoutiao
3,838
$5.70
+3.54%Editas Medicine
10,119
$22.31
-0.76%Bristol-Myers Squibb
7,785
$62.20
+0.10%GE
330,169
$10.91
-3.64%Ford
389,090
$7.26
+0.35%Corbus Pharmaceuticals
49,279
$5.26
+1.64%Gilead Sciences
19,492
$74.56
+6.36%AbbVie
27,119
$88.76
-0.47%Inovio
62,039